641 related articles for article (PubMed ID: 1754866)
1. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
Weiss P; Sarasin C; Ritz R; Pfisterer M
Schweiz Med Wochenschr; 1991 Dec; 121(49):1829-32. PubMed ID: 1754866
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of the first myocardial infarctions with lead ECG --implications in the study of hospital mortality and its reduction using thrombolytic drugs].
Pereira D; de Freitas AD; Caires A; Sousa A; Freitas A; Pereira E; Silva JA; Araújo JJ; de Sousa S; Cardoso AA
Rev Port Cardiol; 1991 Feb; 10(2):141-5. PubMed ID: 2059471
[TBL] [Abstract][Full Text] [Related]
3. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
4. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction.
Birnbaum Y; Herz I; Sclarovsky S; Zlotikamien B; Chetrit A; Olmer L; Barbash GI
J Am Coll Cardiol; 1996 Aug; 28(2):313-8. PubMed ID: 8800103
[TBL] [Abstract][Full Text] [Related]
7. Q wave and Non-Q wave myocardial infarction after thrombolysis.
Matetzky S; Barabash GI; Rabinowitz B; Rath S; Zahav YH; Agranat O; Kaplinsky E; Hod H
J Am Coll Cardiol; 1995 Nov; 26(6):1445-51. PubMed ID: 7594069
[TBL] [Abstract][Full Text] [Related]
8. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
[TBL] [Abstract][Full Text] [Related]
13. Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.
Morgan CD; Gent M; Daly PA; Baigrie RS; Haq A; Roberts RS; Armstrong PW
Can J Cardiol; 1994 Nov; 10(9):897-904. PubMed ID: 7954025
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
Chawla AK; Nambiar CA; Murad AA
Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
[TBL] [Abstract][Full Text] [Related]
15. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients.
Peterson ED; Hathaway WR; Zabel KM; Pieper KS; Granger CB; Wagner GS; Topol EJ; Bates ER; Simoons ML; Califf RM
J Am Coll Cardiol; 1996 Aug; 28(2):305-12. PubMed ID: 8800102
[TBL] [Abstract][Full Text] [Related]
17. [Sex differences in incidence of mortality after acute myocardial infarction].
Trappolini M; Chillotti FM; Rinaldi R; Trappolini F; Coclite D; Napoletano AM; Matteoli S
Ital Heart J Suppl; 2002 Jul; 3(7):759-66. PubMed ID: 12187637
[TBL] [Abstract][Full Text] [Related]
18. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
19. [Successive ischemic events to a first acute myocardial infarct treated with fibrinolysis. An analysis of GISSI-2 patients considered reperfused by a clinical criterion. Participants in the GISSI-2 study. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Bardelli G; Maggi G; Maggi A; Barlera S
G Ital Cardiol; 1995 Apr; 25(4):463-72. PubMed ID: 7642053
[TBL] [Abstract][Full Text] [Related]
20. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
